Literature DB >> 24385646

Integrating health and prevention services in syringe access programs: a strategy to address unmet needs in a high-risk population.

Carolyn K Burr1, Deborah S Storm1, Mary Jo Hoyt1, Loretta Dutton2, Linda Berezny2, Virginia Allread1, Sindy Paul2.   

Abstract

Injection drug users are at a high risk for a number of preventable diseases and complications of drug use. This article describes the implementation of a nurse-led health promotion and disease prevention program in New Jersey's syringe access programs. Initially designed to target women as part of a strategy to decrease missed opportunities for perinatal HIV prevention, the program expanded by integrating existing programs and funding streams available through the state health department. The program now offers health and prevention services to both men and women, with 3,488 client visits in 2011. These services extend the reach of state health department programs, such as adult vaccination and hepatitis and tuberculosis screening, which clients would have had to seek out at multiple venues. The integration of prevention, treatment, and health promotion services in syringe access programs reaches a vulnerable and underserved population who otherwise may receive only urgent and episodic care.

Entities:  

Mesh:

Year:  2014        PMID: 24385646      PMCID: PMC3862985          DOI: 10.1177/00333549141291S105

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  14 in total

1.  Correlates of mother-to-child transmission of HIV in the United States and Puerto Rico.

Authors:  Suzanne K Whitmore; Allan W Taylor; Lorena Espinoza; R Luke Shouse; Margaret A Lampe; Steven Nesheim
Journal:  Pediatrics       Date:  2011-12-05       Impact factor: 7.124

2.  HIV infection and HIV-associated behaviors among injecting drug users - 20 cities, United States, 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-03-02       Impact factor: 17.586

Review 3.  The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: a narrative synthesis of literature.

Authors:  M Mofizul Islam; Libby Topp; Carolyn A Day; Angela Dawson; Katherine M Conigrave
Journal:  Int J Drug Policy       Date:  2011-10-12

4.  Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement.

Authors:  K G Heinzerling; A H Kral; N M Flynn; R L Anderson; A Scott; M L Gilbert; S M Asch; R N Bluthenthal
Journal:  Drug Alcohol Depend       Date:  2005-07-25       Impact factor: 4.492

5.  Effectiveness of needle-exchange programmes for prevention of HIV infection.

Authors:  S F Hurley; D J Jolley; J M Kaldor
Journal:  Lancet       Date:  1997-06-21       Impact factor: 79.321

6.  Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001.

Authors:  Don C Des Jarlais; Theresa Perlis; Kamyar Arasteh; Lucia V Torian; Holly Hagan; Sara Beatrice; Lou Smith; Judith Wethers; Judith Milliken; Donna Mildvan; Stanley Yancovitz; Samuel R Friedman
Journal:  AIDS       Date:  2005-10       Impact factor: 4.177

7.  Access to health and social services for IDU: the impact of a medically supervised injection facility.

Authors:  Will Small; Natasha Van Borek; Nadia Fairbairn; Evan Wood; Thomas Kerr
Journal:  Drug Alcohol Rev       Date:  2009-07

8.  Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.

Authors:  Vicki Peters; Kai-Lih Liu; Kenneth Dominguez; Toni Frederick; Sharon Melville; Ho-Wen Hsu; Idith Ortiz; Tamara Rakusan; Balwant Gill; Pauline Thomas
Journal:  Pediatrics       Date:  2003-05       Impact factor: 7.124

Review 9.  Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.

Authors:  Guthrie S Birkhead; Susan J Klein; Alma R Candelas; Daniel A O'Connell; Jeffrey R Rothman; Ira S Feldman; Dennis S Tsui; Richard A Cotroneo; Colleen A Flanigan
Journal:  Int J Drug Policy       Date:  2007-02-20

10.  Does integrating viral hepatitis services into a public STD clinic attract injection drug users for care?

Authors:  Robin R Hennessy; Isaac B Weisfuse; Karen Schlanger
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

View more
  17 in total

1.  Program collaboration and service integration in the prevention and control of HIV infection, viral hepatitis, STDs, and tuberculosis in the U.S.: lessons learned from the field.

Authors:  Kevin A Fenton; Gustavo A Aquino; Hazel D Dean
Journal:  Public Health Rep       Date:  2014 Jan-Feb       Impact factor: 2.792

2.  Perinatal HIV Service Coordination: Closing Gaps in the HIV Care Continuum for Pregnant Women and Eliminating Perinatal HIV Transmission in the United States.

Authors:  Mary-Margaret Andrews; Deborah S Storm; Carolyn K Burr; Erika Aaron; Mary Jo Hoyt; Anne Statton; Shannon Weber
Journal:  Public Health Rep       Date:  2018-08-10       Impact factor: 2.792

3.  Hepatitis A and Hepatitis B Vaccination Coverage Among Persons Who Inject Drugs and Have Evidence of Hepatitis C Infection.

Authors:  Ruth Koepke; Danielle N Sill; Wajiha Z Akhtar; Kailynn P Mitchell; Sheila M Guilfoyle; Ryan P Westergaard; Stephanie L Schauer; James M Vergeront
Journal:  Public Health Rep       Date:  2019-09-20       Impact factor: 2.792

4.  Availability of HIV and HCV On-Site Testing and Treatment at Syringe Service Programs in the United States.

Authors:  Czarina N Behrends; Ann V Nugent; Don C Des Jarlais; Jemima A Frimpong; David C Perlman; Bruce R Schackman
Journal:  J Acquir Immune Defic Syndr       Date:  2018-10-01       Impact factor: 3.731

5.  Motivation to Change and Treatment Participation Among Syringe Service Program Utilizers in Rural Kentucky.

Authors:  Hilary L Surratt; Janet K Otachi; Timothy Williams; Jennifer Gulley; A Scott Lockard; Rebecca Rains
Journal:  J Rural Health       Date:  2019-08-15       Impact factor: 4.333

6.  Contingency Management and SARS-CoV-2 Testing Among People Who Inject Drugs.

Authors:  Camille C Cioffi; Derek Kosty; Christopher G Capron; Hannah F Tavalire; Robert C Barnes; Anne Marie Mauricio
Journal:  Public Health Rep       Date:  2022-03-03       Impact factor: 3.117

7.  Unmet health care needs and hepatitis C infection among persons who inject drugs in Denver and Seattle, 2009.

Authors:  Alia A Al-Tayyib; Hanne Thiede; Richard D Burt; Stephen Koester
Journal:  Prev Sci       Date:  2015-02

8.  Differences in time to injection onset by drug in California: Implications for the emerging heroin epidemic.

Authors:  Ricky N Bluthenthal; Daniel Chu; Lynn D Wenger; Philippe Bourgois; Thomas Valente; Alex H Kral
Journal:  Drug Alcohol Depend       Date:  2018-02-15       Impact factor: 4.492

9.  Principles of Harm Reduction for Young People Who Use Drugs.

Authors:  Simeon D Kimmel; Jessie M Gaeta; Scott E Hadland; Eliza Hallett; Brandon D L Marshall
Journal:  Pediatrics       Date:  2021-01       Impact factor: 7.124

10.  Drug use and HIV medication adherence in people living with HIV.

Authors:  Nancy Sohler; Deepika Slawek; Valerie Earnshaw; John Jost; Alice Lee; John Mancini; Arielle Mompremier; Chinazo O Cunningham
Journal:  Subst Abus       Date:  2020-01-17       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.